Asia Pacific Cancer Diagnostics Market Size & Outlook
Asia Pacific cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Asia Pacific cancer diagnostics market highlights
- The Asia Pacific cancer diagnostics market generated a revenue of USD 19,647.2 million in 2023.
- The market is expected to grow at a CAGR of 9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 19,647.2 million |
| Market revenue in 2030 | USD 35,952.3 million |
| Growth rate | 9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.3% of the global cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 35,952.3 million by 2030.
Consumables was the largest segment with a revenue share of 59.95% in 2023. Horizon Databook has segmented the Asia Pacific cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific market is expected to grow at a lucrative rate due to various factors, such as increasing healthcare reforms. Other factors contributing to market growth are improving healthcare infrastructure, a growing population, and rising number of local companies entering the market.
Asia Pacific has a large population and high prevalence of cancer. According to Global Cancer Statistics 2020, nearly half of all cases and around 58.3% of cancer deaths globally in 2020 occurred in Asia.
Thus, the usage of screening tests for cancer has increased in the past few years owing to growing government initiatives, such as free screening for cervical cancer, breast cancer, & lung cancer, as well as increasing collaborations between governments, research institutes, & companies for distribution & supply of these tests.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific cancer diagnostics market size, by country, 2018-2030 (US$M)
Asia Pacific Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
